top of page
Search
Illustrative image of surgical needles and financial growth

MANI FY2026 Results: Sales Rise 10.2% as Operating Profit Grows 21.4%

Oct 19
1 min read

October 15, 2026 — Japan-based medical instrument manufacturer MANI, Inc. (Tokyo Stock Exchange: 7730) reported consolidated financial results for the fiscal year ended August 2026.

Annual net sales reached ¥33.018 billion, compared with ¥29.968 billion in FY2025, representing growth of approximately 10.2%. Operating profit increased to ¥9.943 billion from ¥8.193 billion, an increase of approximately 21.4%.

MANI supplies surgical instruments and eyeless needle products, alongside dental products. The consolidated figures include multiple business areas and should not be interpreted as revenue from surgical needles or sutures alone.

The company maintains financial results and investor presentations through its investor relations website.

Source: MANI, Inc., FY2026 financial results and investor relations materials, October 15, 2026. https://mani.co.jp/en/ir/

Image: original illustrative rendering of surgical sutures and financial performance; not a photograph of any named company's products.

 
 
 

Comments


©2022 by MATRIXLabs Medical Inc. All Rights Reserved.

bottom of page